Erythrokeratodermia variabilis (EKV) is a rare autosomal dominant human genodermatosis. Its clinical appearance varies from transient, fast moving erythemas to persistent brown hyperkeratoses. So far, several mutations in the Cx31 or Cx30.3 gene have been reported to cause EKV in humans. We have generated a conditional mouse mutant that carries the human F137L mutation in the Cx31 gene which was described to act in a transdominant negative manner. The phenylalanine residue at position 137 is highly conserved in several human and mouse connexin genes. Mouse embryonic stem (ES) cells expressing one allele of the Cx31F137L mutation were stable but showed 30% decreased transfer of neurobiotin. This is probably due to dominant negative effects of the Cx31F137L protein on wild type Cx31 and Cx43 protein expressed in ES cells. Surprisingly, the healing process of tail incision wounds in Cx31 1/F137L mice was shortened by 1 day, i.e. very similar as previously reported for mice with decreased expression of Cx43 in the epidermis. This suggests again that Cx31 and Cx43 proteins functionally interact, possibly by forming heteromeric channels in the epidermis. Heterozygous Cx31 1/F137L mice are viable and fertile, in contrast to homozygous Cx31 F137L/F137L mice that die around ED 7.5. In Cx31 1/F137L mice, the epidermal expression pattern and level of Cx26, Cx30, Cx30.3 and Cx43 proteins were not altered compared with wild-type mice. No erythemas were detected in young C31
INTRODUCTION
Connexins (Cx) are subunit proteins of gap junction channels which allow the intercellular diffusion of ions and metabolites below a molecular mass of about 1.500 Dalton. Two hemichannels, also called connexons, in contacting plasma membranes can dock to each other to form a gap junction channel. In heterotypic gap junction channels, each hemichannel is composed of a different connexin isoform. Heteromeric hemichannels express more than one type of connexins (1) . Different connexin channels can have distinct molecular permeabilities (2) .
During recent years, several human genodermatoses have been shown to be caused by mutations in Cx26, Cx30, Cx30.3 or Cx31 (3) . Among these inherited diseases are Erythrokeratodermia variabilis (EKV) which is characterized by an unspecific appearance of transient erythemas and locally defined or general hyperkeratosis. Sometimes, one of these features prevails or is completely absent. The variability of the erythematous patches regarding number, size and shape is indicated by the name of the disease. So far, connexin mutations in EKV patients were described in 18 unrelated families, mainly from northern Europe. Seven mutations in the Cx31 gene and five mutations in the Cx30.3 gene were found to cause EKV. In one case, the appearance of EKV could not be correlated with mutations in connexin genes (4) . The clinical symptoms caused by these different connexin mutations are generally not distinguishable. All mutations alter amino acid residues highly conserved in the beta subgroup of connexins, but up to now only mono-allelic mutations have been found. Dominant and transdominant # The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org *To whom correspondence should be addressed. Tel: þ49 228734210; Fax: þ49 228734263; Email: genetik@uni-bonn.de Human Molecular Genetics, 2007, Vol. 16, No. 10 1216-1224 doi:10.1093/hmg/ddm068 Advance Access published on April 19, 2007 negative effects were discussed with Cx30.3 and Cx31 (5, 6) . A recessive variant of EKV was also reported (7) .
The F137L mutation was found both in the Cx31 and the Cx30.3 gene of EKV patients. This mutation was caused by a single point mutation of T to C at position 409 which led to an altered base triplet coding for leucine (L) instead of phenylalanine (F). The phenylalanine residue at position 137 is highly conserved throughout different connexins and different species. Patients suffering from EKV caused by the Cx31F137L mutation show more pronounced phenotypic alterations of the skin (6) .
Expression of the Cx31F137L mutated form in HeLa cells led to the death of transfected cells (8) . In contrast, no effect of the Cx30.3F137L mutation was found after transfection, although this mutation was also discussed to have transdominant negative effects on Cx31 (5, 8) . Cx31 and Cx30.3 proteins can build up heteromeric hemichannels which were shown to be more stable and functional more efficient in dye coupling than corresponding homomeric channels (5) .
Previously, we had found that Cx31 deficient embryos showed a reduced survival probability in utero associated with placental dysmorphogenesis but adult Cx31 deficient mice did not exhibit any epidermal abnormalities (9) . In order to investigate the effects of the Cx31F137L mutation in living animals, we generated transgenic mice that express mutated Cx31 instead of wild-type Cx31 under control of the endogenous Cx31 promoter.
Here, we describe that Cx31 þ/137L mice show largely normal epidermal morphology. Surprisingly, the healing of incision wounds in the tail of these mice was shortened by 1 daysimilar as previously found with Cx43 deficient mice (10) . This suggests that the mutated Cx31 protein can transdominantly affect the wild-type Cx43 protein in the epidermis. Figure 1A illustrates the location of the F137L mutation in the third transmembrane region of the Cx31 protein. This mutation, which was identified in a human patient suffering from EKV, was inserted into the corresponding mouse Cx31 gene. Mouse and human Cx31 coding DNAs show 83% sequence identity. As shown in Figure 1B , the phenylalanine residue at position 137 is highly conserved among several connexins of the beta subgroup. Figure 2A illustrates schematically the construction of the targeting vector and the recombined Cx31 locus after introduction of the Cx31F137L mutation. The mutation was generated by overlapping PCRs and the mutated Cx31 DNA was inserted into a targeting vector which contained a 5 0 -(about 2 kb) and a 3 0 untranslated region (about 5 kb) of the Cx31 locus flanking the endogenous Cx31 coding region (CR), a Neomycin (Neo) selection cassette and the mutated Cx31 coding region (F137L). Since the Neo cassette was flanked by frt sites, it could be removed by Flp recombinase activity. The wild-type Cx31 coding region and the frt flanked Neo cassette were enclosed by loxP sites and thus could be deleted by Cre recombinase activity. Thus, our cloning strategies allowed conditional expression of the Cx31F137L mutation if the corresponding embryos turned out to be lethal.
RESULTS
Using the targeting vector for electroporation of mouse embryonic stem (ES) cells (11) , recombinant clones were isolated at a frequency of 15%. ES cells from these clones were F137L allele showed no difference in comparison to the wild-type allele, because the locus was only altered by one loxP site and a single base exchange causing the mutation. The floxed allele was detected at 11.1 kb and the flox del Neo allele (Dneo) was found at 18.4 kb. (C) PCR, demonstrating the presence of the F137L mutation in the coding region of the Cx31 gene, following DNA digestion with the endonuclease SmlI. The wild-type Cx31 allele yielded an amplicon of 809 bp. This amplicon could be digested with SmlI to yield two fragments of 401 and 408 bp, if the F137L mutation was present. injected into mouse blastocysts, which were then transferred into pseudo pregnant mice. Chimeric progeny due to agouti fur colors were bred to C57BL/6 mice and genomic DNA, digested with the restriction endonucleases NdeI and AgeI, was analyzed by Southern blot hybridization (Fig. 2B) . The floxed Cx31 allele upstream (11.1 kb) and downstream (18.4 kb) of the Neo selection cassette could be distinguished from the wild-type Cx31 allele (15.8 kb) .
The presence of the Cx31F137L mutation was demonstrated by PCR of the Cx31 coding region following DNA digestion with the endonuclease SmlI. An SmlI restriction site is present only in the mutated Cx31F137L but not in the endogenous Cx31 coding region (Fig. 2C ). This mutation was also verified by direct sequencing (data not shown).
Stably transfected Cx31F137L HM1 ES cells were further transiently transfected with a Cre encoding vector, in order to excise the floxed endogenous Cx31 coding region with the Neo selection cassette. After transfection, the mutation was heterozygously expressed in ES cells. These cells were grown to confluency and single cells were injected with neurobiotin. These studies revealed that tracer coupling of cells, which heterozygously expressed this mutation Cx31 þ/F137L , was decreased by 30% in comparison to untransfected ES Cells (Cx31 þ/flox ) (Student's t-test: P ¼ 0.0013) (Fig. 3 ). Since it had been suggested that the Cx31F137L mutation leads to the formation of hemichannels (12) in Ca 2þ free medium, hemichannel activity of mouse ES cells expressing Cx31F137L was evaluated in Ca 2þ free medium using the ATP release assay. No significant change of the ATP concentration in the extracellular solution could be detected in Cx31F137L expressing ES cells (Supplementary Material, Figure S1 ). Furthermore, the ATP release from Cx31
ES cells and wild-type ES cells was not significantly different in Ca 2þ containing medium. Heterozygous Cx31 þ/flox mice were bred with deleter flp mice (13) in order to obtain Cx31 þ/floxdelNeo mice. Additionally, Cx31 þ/flox mice were crossed with PGK-Cre mice to generate Cx31 þ/F137L mice. Mice of these genotypes were fertile and showed no obvious phenotypic abnormalities. However, as listed in Table 1, no Cx31 F137L/F137L mice were born. In order to determine the time of death during embryonic development, we analyzed the genotypes of embryos after interbreeding of Cx31 þ/F137L mice. Living homozygous Cx31 F137L/F137L embryos were found on ED 4.5 and 7.5 but not on ED 8.5 or later until ED 12.5. Thus, the presence of two Cx31F137L alleles appears to be lethal after ED 7.5. In contrast, Cx31 2/F137L mice survived to adulthood. Regarding investigations of mouse skin alterations, we focused first on changes in connexin expression pattern and level. Immunofluorescence analyses of adult Cx31
mice revealed the normal expression pattern of Cx26, Cx30, Cx31 and Cx43 in mouse tail skin, suggesting that intracellular transport of these connexins is not altered by the expression of the Cx31F137L mutation ( Tail incision wounds in Cx31 þ/F137L mice were closed about 1 day earlier than in wild-type mice (Cx31 þ/þ ). Fusion of the epidermis in the mutated animals led to distinct stratification at day 3 of the wound healing process (Fig. 6 ), whereas in wild-type mice this state was only reached at day 4 after wounding. Alterations in the level of other epidermal connexins during the healing of tail incision in wounds were assayed and found to be similar as described by Kretz et al. (10) . Hyperproliferation of epidermal keratinocytes was observed in only 5% of the mutated (Cx31 þ/F137L ) tail skin, but never in wild-type skin (Fig. 7) . Thickening of the epidermis was due to an extended stratum germination suggesting locally enhanced proliferation of keratinocytes in this epidermal area.
DISCUSSION
We chose the human Cx31F137L mutation to introduce it into the Cx31 gene of a transgenic mouse, in order to generate a mouse model for the human genodermatosis EKV. The same point mutation had been found in the Cx30.3 gene of a patient who also suffered from EKV. In order to explain the autosomal dominant inheritance of these mutations, it had been suggested that the mutated Cx31 protein (or the . Cx26 and Cx30 were expressed in the upper-most layers of the epidermis. Occasionally, slight unspecific background fluorescence was noticed at the border between dermis and epidermis. Cx31 immunosignals were also mainly found in the upper epidermal layers. In contrast, Cx43 was expressed in each of the epidermal layers. In several experiments, no significant differences between connexin expression in Cx31 þ/þ (A-D) and Cx31 þ/F137L (E-H) epidermis could be observed. Immunofluorescence was visualized in green and nuclei were stained with propidium iodide (red). Bar represents 20 mm.
homomeric and heteromeric channels, respectively. Alternatively, a trafficking defect of Cx31F137L containing connexons appears possible (12, 14) which could lead to the observed decrease in neurobiotin transfer. This conclusion is in accordance with our observations that Cx31 þ/F137L ES cells do not show increased secretion of ATP (through hemichannels) in Ca 2þ free extracellular medium relative to wild-type ES cells (Supplementary Material, Figure S1 ). Previously, Elfgang et al. (15) mice survived to adulthood, it cannot be the wild-type Cx31 protein that stabilizes the Cx31F137L allele, but presumably other connexin isoform(s) which are expressed in the epidermis. The molecular reasons for the early embryonic death of Cx31 F137L/F137L mice are not known. We speculate that the increased dosage of the mutated protein in homozygous Cx31 F137L/F137L embryos may lead to more extensive functional inhibition of heteromeric channels.
Since hyperkeratosis of EKV is characterized in humans by erythemas and hyperproliferation of the skin, we carefully inspected the Cx31 þ/F137L mice for these symptoms. In young mice (up to two weeks after birth), no erythemas were found. However, during inspection of tail skin, rare cases of hyperproliferation in the stratum germinativum (in 5% of the inspected skin area) were seen in Cx31
mice, but not in Cx31 þ/þ control mice. Thus, the hyperproliferative effect of the Cx31F137L mutation in the skin of transgenic mice appears to be largely compensated by effects of other genes. No effect of the Cx31F137L protein on the level and localization of other epidermal connexin isoforms was seen in the skin of Cx31 þ/F137L mice. This is in accordance with the interpretation that only the activity of Figure 6 . Closure of tail wounds in Cx31 þ/F137L mice (A), in comparison to wild-type Cx31 þ/þ mice (B). On day 3, the wound area in Cx31 þ/F137L skin was already multilayered with punctate Cx31 immunosignals in the reformed epidermis. In contrast, the stratification of the wounded epidermis in wild-type skin had not yet occurred on day 3, and Cx31 immunosignals were sparse. In Cx31 þ/F137L mice, wound healing occurred about 1 day faster, i.e. on day 3 it was equivalent to Cx31 þ/þ wounds on day 4 after wounding. Nuclei and coagulum in the wound were stained with propidium iodide in red. Bar represents 20 mm. ) tail skin (A), but not in wild-type skin (B). The stratum germinativum was extended in 5% of tail skin areas in Cx31 þ/F137L mice. Micrographs show immunofluorescence analyses using anti-Cx31 (green) and propidium iodide staining of nuclei (red). Bar: 20 mm.
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Human Molecular Genetics, 2007, Vol. 16, No. 10 Cx31F137L containing heteromeric gap junction channels is affected, but not their intracellular transport and localization or that of connexons composed of other epidermal connexins (16) . Previously, a transgenic mouse line had been described (17) that expressed a mutant connexin26 (D66H). The corresponding mutation in the human Cx26 gene causes a dominant genodermatosis, the Vohwinkel syndrome. This disease and the phenotype of the transgenic mouse model are characterized by thickening of the epidermal cornified layers and accumulation of the mutated Cx26 protein together with wild-type Cx30 protein in the cytoplasm of keratinocytes. Furthermore, increased apoptosis was found in suprabasal keratinocytes of the mouse mutant. In Cx31 þ/F137L mice of this study, no generalized thickening of the stratum corneum was seen, although this is commonly found in patients suffering from erythrokeratodermia variabilis. The Cx31 þ/F137L mouse mutant should be genetically very similar as the corresponding human patients, since the transgene is expressed at the homologous genomic position from the endogenous Cx31 promoter, like the Cx31 þ/F137L mutation in patients. Thus, the relatively weak keratodermic abnormalities in Cx31 þ/137L mice may reflect a difference in the function of the Cx31 protein in humans and mice. Furthermore, it is possible that the Cx31 þ/F137L mutation shows stronger keratodermic effects in other mouse strains.
Surprisingly, we found that the healing process of incision wounds in tail skin was shortened by 1 day in Cx31
mice when compared with wild-type mice. This result is reminiscent to recent findings that induced downregulation of Cx43 (10) or decreased expression of Cx43 due to localized application of antisense RNA to the skin of wild-type mice (18) resulted in a premature closure of the epidermal wound, compared to non-treated control mice. Our data suggest that the interaction of Cx31 and Cx43 may lead to this effect. Kretz et al. (10) showed that downregulation of the Cx31 protein occurred at about the same time as the decreased Cx43 protein levels, i.e. 1 day after wounding. The transdominant Cx31F137L mutation may have the same inhibitory effect on wild-type Cx31 as downregulation of Cx43 by induced ablation (10) . None of the other epidermal connexins was altered in its expression level in Cx31 þF137L mice (Fig. 5 ). Dye transfer in the epidermis of Cx31 2/2 mice was hardly altered, in contrast to Cx43 ablated mouse epidermis where it was strongly reduced (10) . Which of the different steps of wound healing is affected by transdominant interaction of Cx31 and Cx43 or by the decrease of Cx43 in mouse epidermis needs to be clarified by further investigations.
MATERIALS AND METHODS

Construction of the Cx31F137L targeting vector
The blunted EcoRI -BamHI fragment (2202 bp) from the mouse Cx31 gene locus (19, Fig. 1 ) was inserted into the NotI restriction site of the vector pBSK:lox-HPRT-lox (5693 bp), (20, modified in our laboratory) resulting in vector A1 (7905 bp). Then, another BamHI-Hind III fragment (2369 bp) from the Cx31 gene locus (19, Fig. 1 ) was cloned into pBluescript (2961 bps, Stratagene, La Jolla, USA) at the identical restriction sites. This vector B1 was cut by SalI, followed by insertion of a SalI fragment from the vector pBSK:frt-neo-frt (4796 bp; 13), containing the frt flanked neomycin resistance cassette, in order to generate vector B2 (7214 bp). Cutting out the HPRT minigene of vector A with EcoRI and inserting a NotI-XhoI fragment of vector B2 led to vector AB which now contained the 5 0 -homologous region, the wild-type Cx31 coding region and the frt-flanked Neomycin resistance cassette flanked by loxP sites. The BamHI-XbaI F137L fragment (2677 bp), generated via PCR using DNA of the Cx31 gene locus (19, Fig. 1 ), contained the Cx31 coding region with the point mutation T to C leading to the amino acid shift of F to L. For construction of the mutated coding region, we used the following PCR using primers Eco_mCx31_F (5 0 -G GAA TTC GGC ACC ATG GAC TGG AAG AAG CTC-3 0 ) and mCx31F137LP2 (5 0 -GAT GAG CTT GAG GAT GAG GCT-3 0 ) or Xba_mCx31_R (5 0 -TGC TCT AGA AAT GGG GGT CAG GCT GGG CGC TGA-3 0 ) and mCx31F137LP3 (5 0 -AGC CTC ATC CTC AAG CTC ATC-3 0 ). The two PCR fragments were fused together via a PCR using primers Eco_mCx31_F (5 0 -G GAA TTC GGC ACC ATG GAC TGG AAG AAG CTC-3 0 ) and Xba_mCx31_R (5 0 -TGC TCT AGA AAT GGG GGT CAG GCT GGG CGC TGA-3 0 ). Conditions for all three PCRs were: 5 min at 948C, 30 cycles of 1 min at 948C, 1 min at 558C, 1 min at 728C, followed by 10 min at 728C. PCRs were carried out in 25 ml Taq buffer, containing 1.5 mM MgCl 2 , 1.75 units of Taq polymerase (Promega, Germany), 0.2 mM dNTPs and 20 pmol of each primer. After the PCR reaction, the resulting fragment was digested with BamHI as well as XbaI and cloned into the pBSK vector (2961 bp, Stratagene) which was cut with the same enzymes, resulting in vector C1 (5626 bp). DNA of the Gjb3 locus (9, Fig. 1 ) was cut with XbaI and the resulting fragment (4075 bp) was used as 3 0 -homologous region, inserted into XbaI-cut C1 DNA, resulting in vector C2 (9701 bp). The vector AB was digested with XhoI, the vector C2 with ClaI and NotI. Afterwards both fragments were blunted and ligated to the final Cx31F137L targeting vector (16394 bp).
Screening of ES cell clones
ES cell culture, transfection and analyses were performed as described (11, 21) . G418 resistant ES cell clones were screened for homologous recombination by PCR and were subsequently confirmed by Southern blot hybridization.
The PCR with extracts from Cx31F137L ES cells indicated homologous recombination using the primers Cx31_hom_-For3 (5 0 -CGA AGA TTC TTG CAG TAA TCC A-3 0 ) and Cx31_hom_Rev (5 0 -TAG TTC TAG AGC GGC CAA TTC-3 0 ). PCR conditions were: 3 min at 948C, 35 cycles of 1 min at 948C, 3 min at 668C, 1 min at 728C, followed by 10 min at 728C. PCR was carried out in 50 ml RedTaq-Mix (Sigma, Germany), containing 50 pmol of each primer and 25 ml water.
The Cx31F137L positive ES cell clones were further analyzed by Southern blot analysis of DNA from lysates of about 15 million cells. Digestion of the PCR amplicon was performed by NdeI and AgeI. The probes were generated via PCR using the vector Gx2 (19) 
external probe. The internal probe was generated using the primers probe_int_for (5 0 -CCA CGT GGT TGC TAG TAT TCG-3 0 ) and probe_int_rev (5 0 -GAG AAT CTG ATA ATC AAA CGA C-3 0 ), the external probe using primers probe_ext_for (5 0 -GTT GTC TCT AGA TCT ATA ACC-3 0 ) and probe_ext_rev (5 0 -GTG TTC TAG AAT GAA TGA AGA C-3 0 ). PCR conditions were: 5 min at 948C, 30 cycles of 1 min at 948C, 1 min at 558C, 1 min at 728C, followed by 10 min at 728C. PCR was carried out in 25 ml Taq buffer, containing 1.5 mM MgCl 2 , 1.75 units of Taq polymerase (Promega, Germany), 0.2 mM dNTPs and 20 pmol of each primer.
Characterization of Cx31
1/floxF137L ES cell clones
The homologously recombined ES cells were cultivated on gelatinized cell culture dishes (Falcon, USA) and the transient transfection with the vector pCre-Pac was carried out by electroporation as described by Eckardt et al. (22) . Neurobiotin (N-2 [aminoethyl]-biotinamide hydrochloride; Vector Laboratories, Burlingame, USA) was iontophoretically applied for 2 -4 s in 0.1 M Tris buffer, pH 7.6, using positive current of 20 nA (Ionophoresis Programmer model 160, World precision instruments inc., New Haven, USA). During injection, the cell culture dishes were kept on a heated block at 378C. Five minutes after injection, cells were washed twice with PBS, fixed for 10 min in paraformaldehyde (4%)/0.2% picrinic acid in sodium phosphate buffer (0.15 mM, pH 7.4), washed twice with PBS, incubated in 0.4% Triton X-100, washed with PBS, incubated with horseradish peroxidaseavidin D (Vector Laboratories) for 2 h, washed with PBS, incubated in 0.05% diaminobenzidine, 0.003% hydrogen peroxide solution for 15 min and examined using an inverted microscope (IM35, Zeiss, Oberkochem, Germany).
No difference in morphology was noticed during each series of microinjections with neurobiotin (up to about 1 h) in EScell transfectants.
STATISTICS
All data are represented as mean + standard deviation (SD).
Each of the samples was tested for normality using the Gauss grid method. Samples were subsequently compared using Student's t-test. Samples were considered to be significantly different if P , 0.05.
Extracellular ATP measurements
The ES cells were cultured in gelatinized 35 mm plates to a confluence of 40 -50%, washed twice with PBS and incubated with 500 ml of Hank's balanced salt solution (HBSS) with 1 mM EGTA for 25 min at 378C and 5% CO 2 . After this stimulation, 100 ml of the supernatant were collected and incubated for 20 min with 100 ml of the nucleotide releasing reagent from the ViaLight TM HS kit (Cambrex, East Rutherford, USA). Finally, the ATP concentration was measured for 10 s with the Berthold Microplate LB96V luminometer which automatically added 20 ml of the ATP monitoring reagent. The ATP release could be stimulated by the addition of HBSS with 1 mM EGTA and could be decreased to a basic level by washing cells with PBS-and incubating them in ES cell medium. All results of ATP release were normalized after determination of the total protein amount. Results were expressed as a mean + standard error of the mean (SEM), of relative luciferase activity.
Animals
Mice were kept in accordance with local governmental and institutional instructions for animal care and maintained under a 12/12 hours light/dark cycle. All transgenic mice were of mixed genetic background (at least 75% C57BL/6 and at most 25% 129ola). In order to minimize the possible influence of the genetic background, we performed all analyses with littermates of heterozygote breedings, including control animals that lacked the Cre allele.
Genotyping of transgenic mice
Genotyping of Cre mediated deletion of the floxed region was performed as described previously (21) . Cx31 F137L , Cx31 flox and Cx31 þ alleles were detected by the Cx31F137L PCR, using primers GenotypCreFor' (5 0 -CTC AAA GCT AGT CTG AGA TGC-3 0 ), Cx31hmrev (5 0 -TAG TTC TAG AGC GGC CAA TTC-3 0 ) and GenotypCreRev (5 0 -GCA TCA CAA GGC TCC TAA GAA-3 0 ). PCR conditions were: 5 min at 948C, 30 cycles of 1 min at 948C, 1 min at 608C, 1 min at 728C, followed by 10 min at 728C. PCR was carried out in 25 ml Taq buffer, containing 1.5 mM MgCl 2 , 1.75 units Taq polymerase (Promega, Germany), 0.2 mM dNTPs and 20 pmol of each primer. The F137L mutation was detected by the Cx31CR-PCR, using primers Cx31CR_For (5 0 -GTT CCC TCA GGT GGG CAC AGC-3 0 ) and Cx31CR_Rev (5 0 -CGG CTT CAC CCC TTC TCT AGC-3 0 ) followed by SmlI digestion. PCR conditions were: 4 min at 948C, 35 cycles of 30 s at 948C, 1 min at 558C, 1 min at 728C, followed by 10 min at 728C. PCR was carried out in 50 ml RedTaq-Mix (Sigma, Germany), containing 25 pmol of each primer and 25 ml water. After completing the PCR 5 ml 'buffer 4', 1 ml of SmlI and 5 ml 10-fold concentrated BSA (all from New England Biolabs, Ipswich, USA) are added and the complete mix was incubated for 2 h at 558C. The PCR product was demonstrated as an 809 bp amplicon, the presence of the mutation was proven by two additional bands at 408 bp and 401 bp.
The Cx31 
Immunofluorescence analyses
Cryosections (5 mm) of tail epidermis were stained with the following rabbit antibody solutions: anti-Cx43 (1:2000; 23), anti-Cx31 (1:100; 24), anti-Cx30 (1:300; Zytomed), anti-Cx26 (1:500; Zytomed). Primary antibodies were detected with Alexa594 conjugated goat anti-rabbit immunoglobulin (1:2000; MoBiTech, Goettingen, Germany). For immunofluorescence analyses, cryosections were fixed in 100% ethanol at 2208C for 5 min, blocked with 4% bovine serum albumin (BSA, PAA Laboratories GMBH, Linz, Austria) in phosphate buffered saline (PBS) and incubated with antibodies diluted in 0.4% BSA in PBS overnight at 48C. Afterwards, sections were washed with 0.4% BSA in PBS and incubated with Alexa conjugated antibodies for 1 h at room temperature. Nuclear staining was performed for 15 min with propidium iodide (0.2 mg/ml) in PBS. Slices were mounted with fluorescent mounting medium (Dako, Glostrup, Denmark). Antibody stained tissue slices were analyzed using the photomicroscope Axiophot or the Laser Scan Microscope (both from Zeiss, Jena, Germany). Sections of tissues from the corresponding connexin deficient mice were used as negative controls. HeLa cells stably transfected with the corresponding connexin expression vector or sections of connexin expressing tissues were used as positive controls.
Preparation of skin sections and histochemistry
Mice were killed by cervical dislocation. The tail skin was dissected, immediately frozen in liquid nitrogen and stored at 2708C. Tail epidermis was cut lengthwise (10 mm sections) with a cryostat.
Wounding and isolation of mouse tail skin
Incision wounds into mouse tail were cut with a scalpel, as previously described for rat tail (25) . Six to eight transverse sections through the tail skin with a length of 1 cm were performed per mouse. Two of them were processed for immunofluorescence, two for histological and four were used for immunoblot analyses. At each time point after wounding, mutated and control mice were analyzed.
